Realcan Pharmaceutical Group Co (SZSE:002589) Days Sales Outstanding : 174.33 (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Realcan Pharmaceutical Group Co Days Sales Outstanding?

Realcan Pharmaceutical Group Co's average Accounts Receivable for the three months ended in Mar. 2024 was ¥3,857 Mil. Realcan Pharmaceutical Group Co's Revenue for the three months ended in Mar. 2024 was ¥2,019 Mil. Hence, Realcan Pharmaceutical Group Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 174.33.

The historical rank and industry rank for Realcan Pharmaceutical Group Co's Days Sales Outstanding or its related term are showing as below:

SZSE:002589' s Days Sales Outstanding Range Over the Past 10 Years
Min: 131.7 Med: 164.27 Max: 213.43
Current: 180.22

During the past 13 years, Realcan Pharmaceutical Group Co's highest Days Sales Outstanding was 213.43. The lowest was 131.70. And the median was 164.27.

SZSE:002589's Days Sales Outstanding is ranked worse than
87.5% of 96 companies
in the Medical Distribution industry
Industry Median: 76.76 vs SZSE:002589: 180.22

Realcan Pharmaceutical Group Co's Days Sales Outstanding declined from Mar. 2023 (180.99) to Mar. 2024 (174.33).

Realcan Pharmaceutical Group Co Days Sales Outstanding Historical Data

The historical data trend for Realcan Pharmaceutical Group Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Realcan Pharmaceutical Group Co Days Sales Outstanding Chart

Realcan Pharmaceutical Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

169.78

196.76

208.06

213.43

178.89

Realcan Pharmaceutical Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															180.99	183.68	177.46	181.41	174.33

Competitive Comparison of Realcan Pharmaceutical Group Co's Days Sales Outstanding

For the Medical Distribution subindustry, Realcan Pharmaceutical Group Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Realcan Pharmaceutical Group Co's Days Sales Outstanding Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Realcan Pharmaceutical Group Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Realcan Pharmaceutical Group Co's Days Sales Outstanding falls into.

Realcan Pharmaceutical Group Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Realcan Pharmaceutical Group Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (4112.369	+	3762.988)	/	2 )	/	8034.368	*	365
=	3937.6785					/	8034.368	*	365
=	178.89

Realcan Pharmaceutical Group Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (3762.988	+	3950.733)	/	2 )	/	2018.759	*	365 / 4
=	3856.8605					/	2018.759	*	365 / 4
=	174.33

Realcan Pharmaceutical Group Co (SZSE:002589) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Realcan Pharmaceutical Group Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Realcan Pharmaceutical Group Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Realcan Pharmaceutical Group Co (SZSE:002589) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Realcan Pharmaceutical Group Co Ltd (SZSE:002589) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 326, Airport Road, Zhifu District, Shandong Province, Yantai, CHN, 264004

Website

http://www.realcan.cn

Realcan Pharmaceutical Group Co Ltd is a Chinese company engaged in direct pharmaceuticals distribution services. The company's main business is divided into the Drug, vaccine, medical device circulation service; Medical industry third-party logistics; Medical information service; Medical logistics service; Chinese medicine plate; Hospital management sector; Medical industry research and development production sector; and Medical industry financial sector.

Realcan Pharmaceutical Group Co (SZSE:002589) Headlines

No Headlines